A Tribute to Paul Greengard, Volume 90 , the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this release presenting a tribute to Paul Greengard.
A Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this release presenting a tribute to Paul Greengard.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Stevin Zorn is President and CEO at MindImmune Therapeutics, Inc., Kingston, RI, USA
Inhaltsangabe
1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari 2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity Fabio Benfenati, Martin Bähler and Flavia Valtorta 3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases Kyle R. Christensen and Angus C. Nairn 4. DARPP-32 40 years later Jean-Antoine Girault and Angus C. Nairn 5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction Angela M. Lee and Marina R. Picciotto 6. Modulation of dendritic spines by protein phosphatase-1 Jimcy Platholi and Hugh C. Hemmings Jr 7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez 8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction Marine Salery, Arthur Godino and Eric J. Nestler 9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli 10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1 Victor Bustos, Maria Pulina and Jose Ledo 11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates 12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases? James K.T. Wang
1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari 2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity Fabio Benfenati, Martin Bähler and Flavia Valtorta 3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases Kyle R. Christensen and Angus C. Nairn 4. DARPP-32 40 years later Jean-Antoine Girault and Angus C. Nairn 5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction Angela M. Lee and Marina R. Picciotto 6. Modulation of dendritic spines by protein phosphatase-1 Jimcy Platholi and Hugh C. Hemmings Jr 7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez 8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction Marine Salery, Arthur Godino and Eric J. Nestler 9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli 10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1 Victor Bustos, Maria Pulina and Jose Ledo 11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates 12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases? James K.T. Wang
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
